Sergey Sheleg

Sergey Sheleg

Auto-generated profile, based on publicly available information

Sergey Sheleg

ENIT, Inc.,Scottsdale,USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Cancer Research
Verified
Journal Article
Open access
PDF file
YIYoichi Iwanaga
Yoichi Iwanaga
YCYa-Hui Chi
Ya-Hui Chi
AMAkiko Miyazato
Akiko Miyazato
SSSergey Sheleg
Sergey Sheleg
KHKerstin Haller
Kerstin Haller
KJKuan-Teh Jeang
Kuan-Teh Jeang
Mitotic arrest–deficient protein 1 (MAD1) is a component of the mitotic spindle assembly checkpoint. We have created a knockout mouse model to examine the physiologic consequence of reduced MAD1 function. Mad1+/− mice were successfully generated, but repeated paired mating of Mad1+/− with Mad1+/− mice failed to produce a single Mad1−/− animal, suggesting that the latter genotype is embryonic lethal. In aging studies conducted for >18 months, Mad1+/− mice compared with control wild-type (wt) littermates showed a 2-fold higher incidence of constitutive tumors. Moreover, 42% of Mad1+/− (P < 0.03), but 0% of wt, mice developed neoplasia after treatment with vincristine, a microtubule depolymerization agent. Mad1+/− mouse embryonic fibroblasts (MEF) were found to be more prone than wt cells to become aneuploid; Mad1+/−, but not wt, MEFs produced fibrosarcomas when explanted into nude mice. Our results indicate an essential MAD1 function in mouse development and correlate Mad1 haploinsufficiency with increased constitutive tumors. [Cancer Res 2007;67(1):160–6]

23 January 2004 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
PDF file
SSSergey V. Sheleg
Sergey V. Sheleg
EZEdvard A. Zhavrid
Edvard A. Zhavrid
TKTatsiana V. Khodina
Tatsiana V. Khodina
GKGeorgy A. Kochubeev
Georgy A. Kochubeev
YIYury P. Istomin
Yury P. Istomin
IZIvan N. Zhuravkin
Ivan N. Zhuravkin

1 October 2002 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
SSSergey V. Sheleg
Sergey V. Sheleg
EKEugeny A. Korotkevich
Eugeny A. Korotkevich
EZEdvard A. Zhavrid
Edvard A. Zhavrid
GMGalina V. Muravskaya
Galina V. Muravskaya
ASArnold F. Smeyanovich
Arnold F. Smeyanovich
SBSergey A. Belyaev
Sergey A. Belyaev

1 December 2011 in Journal of Addiction Medicine
Verified
Journal Article
Closed access
SSSergey V. Sheleg
Sergey V. Sheleg
GCGregory B. Collins
Gregory B. Collins
Here we present a case of a coincidence of addiction to "Kratom" (botanically known as Mitragyna speciosa Korth) and developed severe primary hypothyroidism. We are discussing a possibility that high dose of indole alkaloid mitragynine (the major alkaloid identified from "Kratom") might reduce the normal response of the thyroid gland to thyroid-stimulating hormone resulting in primary hypothyroidism. Further experimental investigations of mitragynine as a possible suppressor of thyroid gland function would be a matter of interest.

1 July 2005 in Journal of Virology
Verified
Journal Article
Open access
PDF file
AMAkiko Miyazato
Akiko Miyazato
SSSergey Sheleg
Sergey Sheleg
HIHidekatsu Iha
Hidekatsu Iha
YLYan Li
Yan Li
KJKuan-Teh Jeang
Kuan-Teh Jeang
The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein can repress the transcriptional activity of the tumor suppressor protein p53. However, it remains controversial whether Tax requires NF-κB factors/activity and/or p300/CBP in order to inactivate p53 function. To address this issue, we have investigated Tax's effect on p53's transcriptional activation in IκB-kinase-deficient mouse embryonic fibroblasts (MEFs); some of which are entirely silent for Tax-induced NF-κB activity. We found that, in IKKα−/−, IKKβ−/−, and IKKγ−/− MEFs, p53 activation of a prototypic responsive plasmid (pG13-luciferase) was repressed by wild-type Tax. Curiously, p53's activity in MEFs was also repressed by a p300/CBP-binding deficient Tax protein. Our results highlight the complex nature of Tax-mediated repression of p53- activity, which requires further investigation.

1 October 2001 in Journal of Neurosurgery
Verified
Journal Article
Closed access
SSSergey V. Sheleg
Sergey V. Sheleg
MNMikhail K. Nedzved
Mikhail K. Nedzved
Alexander NedzvedAlexander Nedzved
Alexander Nedzved
IKInna V. Kulichkovskaya
Inna V. Kulichkovskaya